These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30121307)

  • 1. Long non-coding RNA activated by TGF-β expression in cancer prognosis: A meta-analysis.
    Shen X; Piao L; Zhang S; Cui Y; Cui Y; Quan X; Sun H
    Int J Surg; 2018 Oct; 58():37-45. PubMed ID: 30121307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA activated by TGF-β in human cancers: A meta-analysis.
    Fan YH; Ji CX; Xu B; Fan HY; Cheng ZJ; Zhu XG
    Clin Chim Acta; 2017 May; 468():10-16. PubMed ID: 28163033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis.
    Yue B; Qiu S; Zhao S; Liu C; Zhang D; Yu F; Peng Z; Yan D
    J Gastroenterol Hepatol; 2016 Mar; 31(3):595-603. PubMed ID: 26487301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
    Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A long noncoding RNA, lncRNA-ATB, is involved in the progression and prognosis of colorectal cancer.
    Iguchi T; Uchi R; Nambara S; Saito T; Komatsu H; Hirata H; Ueda M; Sakimura S; Takano Y; Kurashige J; Shinden Y; Eguchi H; Sugimachi K; Maehara Y; Mimori K
    Anticancer Res; 2015 Mar; 35(3):1385-8. PubMed ID: 25750289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA ZEB1-AS1 expression in cancer prognosis: Review and meta-analysis.
    Chen C; Feng Y; Wang X
    Clin Chim Acta; 2018 Sep; 484():265-271. PubMed ID: 29885321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of lncRNA-ATB correlates with clinical progression and unfavorable prognosis in pancreatic cancer.
    Qu S; Yang X; Song W; Sun W; Li X; Wang J; Zhong Y; Shang R; Ruan B; Zhang Z; Zhang X; Li H
    Tumour Biol; 2016 Mar; 37(3):3933-8. PubMed ID: 26482611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA activated by transforming growth factor-β promotes cancer development and is a prognostic marker in cervical cancer.
    Cao W; Peng T; Zhou Y
    J Cancer Res Ther; 2017; 13(5):801-806. PubMed ID: 29237907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of long noncoding RNA Sox2ot expression in various cancers: A systematic review and meta-analysis.
    Song X; Yao H; Liu J; Wang Q
    Clin Chim Acta; 2018 Sep; 484():52-59. PubMed ID: 29787741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of long noncoding RNA activated by TGF-β in digestive system cancers: A meta-analysis.
    Duan H; Ding X; Luo H
    Medicine (Baltimore); 2020 Jul; 99(30):e21324. PubMed ID: 32791727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of long non-coding RNA lncRNA-ATB is correlated with metastases and promotes cell migration and invasion in renal cell carcinoma.
    Xiong J; Liu Y; Jiang L; Zeng Y; Tang W
    Jpn J Clin Oncol; 2016 Apr; 46(4):378-84. PubMed ID: 26848077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of lncRNA-ATB expression in malignant solid tumors: A meta-analysis.
    Wang B; Lu Z; Huang Y; Lin T
    Pathol Res Pract; 2020 Apr; 216(4):152897. PubMed ID: 32146004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of lncRNA ROR expression in various cancers: a meta-analysis.
    Lu R; Chen J; Kong L; Zhu H
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30076198
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic value of long non-coding RNA ATB in digestive system cancers: A meta-analysis.
    Cheng XB; Fu B; Li XZ; Jiang Y
    Pathol Res Pract; 2020 Jun; 216(6):152949. PubMed ID: 32307201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer.
    El-Ashmawy NE; Hussien FZ; El-Feky OA; Hamouda SM; Al-Ashmawy GM
    Life Sci; 2020 Oct; 259():118193. PubMed ID: 32763293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.
    Xu S; Yi XM; Tang CP; Ge JP; Zhang ZY; Zhou WQ
    Oncol Rep; 2016 Jul; 36(1):10-22. PubMed ID: 27176634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of the long non-coding RNA, SPRY4 Intronic Transcript 1, in patients with cancer: a meta-analysis.
    Wang M; Dong X; Feng Y; Sun H; Shan N; Lu T
    Oncotarget; 2017 May; 8(20):33713-33724. PubMed ID: 28410241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of long non-coding RNA ATB is associated with poor prognosis in patients with renal cell carcinoma.
    Qi JJ; Liu YX; Lin L
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2835-2839. PubMed ID: 28682434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of prognostic value of lncRNA BANCR in tumor patients: A systematic review and meta-analysis.
    Zhang G; Cai J
    J BUON; 2019; 24(6):2553-2559. PubMed ID: 31983132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and clinicopathological value of long noncoding RNA XIST in cancer.
    Zhu J; Kong F; Xing L; Jin Z; Li Z
    Clin Chim Acta; 2018 Apr; 479():43-47. PubMed ID: 29307668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.